These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3502553)
1. [Use of miocamycin in respiratory tract diseases]. Rimoldi R; Fioretti M; Bandera M Ann Ist Super Sanita; 1987; 23(4):891-4. PubMed ID: 3502553 [No Abstract] [Full Text] [Related]
2. Combination therapy using 9,3"-di-O-acetyl-midecamycin with beta-lactam antibiotics against Pseudomonas aeruginosa infection. Mashimo K; Homma JY; Iki Y; Inatomi K; Kasai T; Kunii O; Shimada K; Tanimoto H; Takigami T; Nishimura Y Jpn J Exp Med; 1981 Oct; 51(5):271-85. PubMed ID: 6798249 [TBL] [Abstract][Full Text] [Related]
3. [Miocamycin in the therapy of bacterial infections in childhood]. Peruzzi PF; Ulivelli A Clin Ter; 1988 Apr; 125(2):107-13. PubMed ID: 2973931 [No Abstract] [Full Text] [Related]
4. Comparison of miocamycin versus amoxycillin in lower respiratory tract infections in children. Clinical response and effect on natural killer activity. Agostoni C; Giovannini M; Fraschini F; Scaglione F; Galluzzo C; Riva E; Ferrara F J Int Med Res; 1988; 16(4):305-11. PubMed ID: 3262546 [TBL] [Abstract][Full Text] [Related]
5. [Clinical contribution to the therapy of acute bronchopneumopathic diseases with the use of antibiotics associated with curative vaccines]. Fossati C Minerva Med; 1968 Jan; 59(5):164-72. PubMed ID: 5639121 [No Abstract] [Full Text] [Related]
6. [A clinical study of rokitamycin dry syrup in pediatric infections]. Fukushima N; Wagatsuma Y; Takase A; Ishikawa A; Hattori T Jpn J Antibiot; 1988 Jul; 41(7):854-8. PubMed ID: 3172458 [TBL] [Abstract][Full Text] [Related]
7. [Miocamycin in pediatrics. Results of multicenter study in Piedmont and Valle d'Aosta]. De Sario PN; Bianco R; De Marco A; Gavioli F; Orecchia L; Salvadori G; Stradoni P Ann Osp Maria Vittoria Torino; 1986; 29(7-12):317-28. PubMed ID: 3329481 [TBL] [Abstract][Full Text] [Related]
8. [Clinical use of midecamycin. Apropos of 60 cases]. Ghanassia JP; Domart A G Ital Chemioter; 1977; 24(1-2):63-5. PubMed ID: 615764 [No Abstract] [Full Text] [Related]
9. [Pharmacokinetics and tissue distribution of miocamycin]. Fraschini F; Scaglione F; Cantarella G; Marchi E; Scarpazza P Ann Ist Super Sanita; 1987; 23(4):887-90. PubMed ID: 3502552 [No Abstract] [Full Text] [Related]
10. [Clinical study of a new macrolide, miocamycin, in 150 patients with otorhinolaryngologic disorders]. Ursino F; Grosjacques M; Panattoni G; Pardini L; Matteucci F Clin Ter; 1987 Jul; 122(1):13-6. PubMed ID: 2973891 [No Abstract] [Full Text] [Related]
11. [Miocamycin: multicenter clinical study in patients with bacterial infections of the upper respiratory tract]. Marni E; Salvatoni A; Martignoni L; Visantino S; Binda S G Ital Chemioter; 1987; 34(1-3):63-71. PubMed ID: 3332870 [No Abstract] [Full Text] [Related]
12. [Antimicrobial activity of josamycin in the respiratory tract]. Wildfeuer A; Seibold H; Lemme JD Fortschr Med; 1985 Feb; 103(7):155-8. PubMed ID: 3972331 [No Abstract] [Full Text] [Related]
13. [Clinical use and evaluation of 9,3"-di-0-acetyl midecamycin (MOM) in oral surgery]. Satoh T; Sugiura Y; Fujiwara H; Suzuki M; Takahashi K; Saigusa F; Nishida K; Hisano Y Shigaku; 1982 Jun; 70(1):126-36. PubMed ID: 6985345 [No Abstract] [Full Text] [Related]
14. [The use of amikacin in pneumology]. Olivieri D; Cantatore D; Argenziano A; D'Agostino F Arch Monaldi; 1980; 35(3):127-33. PubMed ID: 7316662 [No Abstract] [Full Text] [Related]
15. [Evaluation of the efficacy and tolerability of miocamycin in the treatment of otorhinololaryngologic infection by sensitive micro-organisms]. Bellioni P; Di Luzio Paparatti U; Salvinelli F; Artuso A Riv Eur Sci Med Farmacol; 1987 Sep; 9(3):293-8. PubMed ID: 3509888 [No Abstract] [Full Text] [Related]
16. Miocamycin doesn't affect theophylline serum levels in COPD patients. Dal Negro R; Turco P; Pomari C; de Conti F Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):27-9. PubMed ID: 3261281 [TBL] [Abstract][Full Text] [Related]
17. [Clinical studies on TMS-19-Q.O tablet in respiratory tract infection]. Hara K; Izumikawa K; Suzuyama Y; Shigeno Y; Komori M; Tomita H; Sai M; Ikebe A; Iwasaki H; Saito A Jpn J Antibiot; 1985 Mar; 38(3):553-74. PubMed ID: 3897599 [TBL] [Abstract][Full Text] [Related]
18. [Clinical results of 9, 3"-diacetylmidecamycin dry syrup in the pediatric field (author's transl)]. Takimoto M; Oki J; Yoshioka H; Takase A; Nagamatsu I Jpn J Antibiot; 1982 Mar; 35(3):766-9. PubMed ID: 6980294 [TBL] [Abstract][Full Text] [Related]
19. [On the therapy of infectious bronchopneumopathies in children]. Della Casa R; Vitolo G; Sicuranza R Minerva Pediatr; 1967 Mar; 19(10):457-62. PubMed ID: 5607051 [No Abstract] [Full Text] [Related]
20. Enoxacin in the treatment of lower respiratory tract infections. Philip-Joet F; Nourrit J; Frances Y; Arnaud A J Antimicrob Chemother; 1988 Feb; 21 Suppl B():125-9. PubMed ID: 3258863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]